Eye Care Firm Bausch + Lomb Seeks To Raise $630 Million In NYSE, TSX IPOs

Bausch Health Companies (NYSE/TSX: BHC) subsidiary, eye health company Bausch + Lomb Corporation (NYSE/TSX: BLCO) started trading its securities today. The firm announced today that it is seeking to raise a total of $630 million in its initial public offering for New York Stock Exchange and Toronto Stock Exchange boards.

The proposed offering will be conducted through the issuance of 35.0 million company units selling at $18.00 per share. All of the shares being offered are held by the selling shareholder, Bausch Health. As a result, the parent firm will hold 90% equity in the subsidiary post-closing of the offering.

The offering is being managed by Morgan Stanley and Goldman Sachs & Co. leading a syndicate of underwriters, which were given a 30-day overallotment option to purchase additional 5.25 million shares at the same IPO price.

The Ontario-based eye health firm has a portfolio of more than 400 products including contact lenses, lens care products, and eye care products, among others. The firm now has 12,000 employees and a presence in nearly 100 countries, with corporate offices in New Jersey.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why $50 Silver, $4000 Gold Might Be Closer Than Anyone Thinks | Bradley Langille – GoGold Resources

Why Silver’s True Price Could Be Much Higher | Joaquín Marias – Argenta Silver

Gold Enters A ‘Stronger For Longer’ Phase | Richard Young – i-80 Gold

Recommended

Emerita Resources Intersects Further Mineralization At El Cura, Expanding Deposit

ESGold Sees ANT Survey Reveal Vertically Continuous System To 1,200 Metres Depth

Related News

Robinhood Creating Platform to Allow Amateur Investors to Buy IPOs, Including its Own

While still brushing off daytrader anguish and congressional scrutiny after its decision to pause trading...

Saturday, March 27, 2021, 11:21:00 AM

Biotech SPAC Larkspur Health Acquisition Prices US$75 Million IPO

After filing for registration in May 2021, special purpose acquisition company Larkspur Health Acquisition Corp....

Tuesday, December 21, 2021, 01:54:00 PM

Electric Sports Boat Maker Forza X1 Prices US$15 Million IPO

Recreational boating firm Forza X1 (Nasdaq: FRZA) started trading its shares on the Nasdaq Capital...

Friday, August 12, 2022, 02:10:00 PM

Edtech Firm Genius Group Prices US$19.6 Million IPO

Edtech and education group Genius Group Limited (NYSE: GNS) began trading on the New York...

Tuesday, April 12, 2022, 02:19:00 PM

Biotech Firm AN2 Therapeutics Prices US$69 Million IPO

Biopharmaceutical company AN2 Therapeutics, Inc. (Nasdaq: ANTX) began trading on the Nasdaq Global Select Market...

Friday, March 25, 2022, 02:22:00 PM